Nyxoah Reports Progress on U.S. Genio Launch and Reimbursement Stability
Nyxoah SA (NASDAQ:NYXH) highlighted progress in the U.S. launch of its Genio hypoglossal nerve stimulation system, including trained surgeons, ordering customers, and prior authorization patients. The company also confirmed stable reimbursement despite recent CMS code changes.
Tickers: $NYXH
Topics: medical_devices reimbursement_stability sleep_apnea_treatment